- Edgewise to advance heart drug into Phase 3 following mid-stage data updateEdgewise Therapeutics has shared plans to advance its drug candidate for a genetic heart disease into a registrational study on the back of updated Phase 2 data. The biotech said Tuesday ...Endpoints · 1mo ago↗ source
- The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nationsInfant mortality in the U.S. dropped to a new all-time low in 2025, according to CDC data, though it still trails other similar nations.STAT · 1mo ago↗ source
- How to launch a telehealth business in one dayWant to prescribe GLP-1s online? OpenLoop Health says it can get your virtual care company up and running in as little as 24 hours. OpenLoop provides the behind-the-scenes medical group powering…